This is a grant application about the function and regulation of Akt signaling in the mammary gland vasculature during normal mammary gland development and tumor progression. To better understand the impact of Akt signaling on the whole mammary tumor, we also explore potential differences in RhoB-mediated regulation of the Akt pathway in tumor cells because there is evidence that this pathway is significantly different between the tumor and stromal compartments.
Specific Aims :
Aim 1 : Examine the impact of endothelial cell Akt expression on tumor growth and metastasis and on epithelial involution in the normal and tumor bearing mammary gland.
Aim 2 : Evaluate the impact of a RhoB modulation of Akt signaling in the tumor stroma versus epithelium during tumor progression. Innovative Aspects. 1. The use of inducible tissue specific transgenic mice to study the role of Akt signaling in vivo. 2. The side-by-side analysis of Akt function in normal versus tumor-bearing mammary glands. 3. The investigation of a novel Akt regulator, RhoB, with reportedly opposing functions in tumor cells and endothelial cells. 4. The investigation of interactions and functional redundancy between small GTPases with respect to Akt regulation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA109086-04
Application #
7245097
Study Section
Special Emphasis Panel (ZRG1-TME (01))
Program Officer
Sathyamoorthy, Neeraja
Project Start
2004-09-01
Project End
2009-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
4
Fiscal Year
2007
Total Cost
$330,443
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Kazerounian, Shiva; Gerald, Damien; Huang, Minzhou et al. (2013) RhoB differentially controls Akt function in tumor cells and stromal endothelial cells during breast tumorigenesis. Cancer Res 73:50-61
Nagy, Janice A; Benjamin, Laura; Zeng, Huiyan et al. (2008) Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11:109-19
Phung, Thuy L; Oble, Darryl A; Jia, Wangcun et al. (2008) Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks Lasers Surg Med 40:1-5
Takeda, Yoshito; Kazarov, Alexander R; Butterfield, Catherine E et al. (2007) Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 109:1524-32
Phung, Thuy L; Eyiah-Mensah, Godfred; O'Donnell, Rebekah K et al. (2007) Endothelial Akt signaling is rate-limiting for rapamycin inhibition of mouse mammary tumor progression. Cancer Res 67:5070-5
Phung, Thuy L; Ziv, Keren; Dabydeen, Donnette et al. (2006) Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell 10:159-70
Sun, Jing Fang; Phung, Thuy; Shiojima, Ichiro et al. (2005) Microvascular patterning is controlled by fine-tuning the Akt signal. Proc Natl Acad Sci U S A 102:128-33
Sund, Malin; Hamano, Yuki; Sugimoto, Hikaru et al. (2005) Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc Natl Acad Sci U S A 102:2934-9